10:27 AM EDT, 09/08/2025 (MT Newswires) -- Edap TMS ( EDAP ) shares were up more than 11% in recent Monday trading after the company said the French Ministry of Health will reimburse eligible patients for its Focal One robotic high-intensity focused ultrasound procedure to treat prostate cancer.

Coverage of the Focal One robotic high-intensity focused ultrasound procedure under France's national universal health system became effective on Sept. 1, and reimbursement details will be available soon, the company said.

Price: 2.81, Change: +0.29, Percent Change: +11.31